| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8485730 | Vaccine | 2018 | 13 Pages |
Abstract
Well-designed cost-effectiveness studies of PPV23 that represent the current epidemiological scenario and reduce uncertainty related to efficacy/effectiveness are extremely relevant to informing the decision-making process.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Alvaro Mitsunori Nishikawa, Ana Marli Christovam Sartori, Giulia Marcelino Mainardi, Angela Carvalho Freitas, Alexander Itria, Hillegonda Maria Dutilh Novaes, PatrÃcia Coelho de Soárez,